Publication Listing for the MeSH term esophageal cancer. Found 21 abstracts

no pagination

Bakhos C, Patel S, Petrov R, Abbas A. Jejunostomy-technique and controversies. Journal of visualized surgery. 2019 Apr;5.   PMCID: PMC6638548

Saxena R, Klochkova A, Murray MG, Kabir MF, Samad S, Beccari T, Gang J, Patel K, Hamilton KE, Whelan KA. Roles for Autophagy in Esophageal Carcinogenesis: Implications for Improving Patient Outcomes. Cancers. 2019 Oct 31;11(11).

Dalton BG, Friedant AJ, Su S, Schatz TA, Ruth KJ, Scott WJ. Benefits of Supplemental Jejunostomy Tube Feeding During Neoadjuvant Therapy in Patients with Locally Advanced, Potentially Resectable Esophageal Cancer. Journal of laparoendoscopic & advanced surgical techniques Part A. 2017 Dec;27(12):1279-83.

Gerson JN, Skariah S, Denlinger CS, Astsaturov I. Perspectives of HER2-targeting in gastric and esophageal cancer. Expert opinion on investigational drugs. 2017 May;26(5):531-40.   PMCID: PMC5563845

Malik F, Ali N, Durrani J, Mustafa SI, Denlinger C. Case series of multiple primary cancers in single individuals: diagnostic and therapeutic dilemmas. Journal of community hospital internal medicine perspectives. 2017 Oct;7(4):238-40.   PMCID: PMC5637644

Shaikh T, Meyer JE, Horwitz EM. Optimal Use of Combined Modality Therapy in the Treatment of Esophageal Cancer. Surg Oncol Clin N Am. 2017 Jul;26(3):405-29.   PMCID: REVIEW

Persson EC, Sewram V, Evans AA, London WT, Volkwyn Y, Shen YJ, Van Zyl JA, Chen G, Lin WY, Shephard GS, Taylor PR, Fan JH, Dawsey SM, Qiao YL, McGlynn KA, Abnet CC. Fumonisin B-1 and risk of hepatocellular carcinoma in two Chinese cohorts. Food and Chemical Toxicology. 2012 Mar;50(3-4):679-83.   PMCID: PMC3299856

Showalter TN, Winter KA, Berger AC, Regine WF, Abrams RA, Safran H, Hoffman JP, Benson AB, MacDonald JS, Willett CG. THE INFLUENCE OF TOTAL NODES EXAMINED, NUMBER OF POSITIVE NODES, AND LYMPH NODE RATIO ON SURVIVAL AFTER SURGICAL RESECTION AND ADJUVANT CHEMORADIATION FOR PANCREATIC CANCER: A SECONDARY ANALYSIS OF RTOG 9704. International Journal of Radiation Oncology Biology Physics. 2011 Dec;81(5):1328-35.   PMCID: PMC3038247

Burtness B, Gibson M, Egleston B, Mehra R, Thomas L, Sipples R, Quintanilla M, Lacy J, Watkins S, Murren JR, Forastiere AA. Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancer. Annals of Oncology. 2009 Jul;20(7):1242-8.   PMCID: PMC2699385

Takaoka M, Kim SH, Okawa T, Michaylira CZ, Stairs DB, Johnstone CN, Andl CD, Rhoades B, Lee JJ, Klein-Szanto AJ, El-Deiry WS, Nakagawa H. IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms. Cancer Biology & Therapy. 2007 Apr;6(4):534-40.

Henry LR, Goldberg M, Scott W, Konski A, Meropol NJ, Freedman G, Weiner LM, Watts P, Beard M, McLaughlin S, Cheng JD. Induction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: A phase II report. ANNALS OF SURGICAL ONCOLOGY. 2006 Feb;13(2):214-20.

Konski A, Doss M, Milestone B, Haluszka O, Hanlon A, Freedman G, Adler L. The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma. International Journal of Radiation Oncology Biology Physics. 2005 Mar 15;61(4):1123-8.

Tanisada K, Teshima T, Ohno Y, Inoue T, Abe M, Ikeda H, Owen JB, Hanks GE, Masuda K, Honke Y, Japanese Patterns Care S. Patterns of care study quantitative evaluation of the quality of radiotherapy in Japan. Cancer. 2002 Jul;95(1):164-71.

Tanisada K, Teshima T, Ikeda H, Abe M, Owen JB, Hanks GE, Yamashita T, Nishio M, Yamada S, Sakai K, Hiraoka M, Hirokawa Y, Oguchi M, Inoue T. A preliminary outcome analysis of the patterns of care study in Japan for esophageal cancer patients with special reference to age: Non surgery group. International Journal of Radiation Oncology Biology Physics. 2000 Mar 15;46(5):1223-33.

Sauter ER, Nesbit M, Litwin S, Klein-Szanto AJ, Cheffetz S, Herlyn M. Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas. Cancer Research. 1999 Oct;59(19):4876-81.

Barnabas N, Moraes R, Calaf G, Estrada S, Russo J. Role of P53 in Mcf-10f Cell Immortalization and Chemically- Induced Neoplastic Transformation. International Journal of Oncology. 1995 Dec;7(6):1289-96.

Fortunato L, Ridge JA. Surgical Palliation of Cancer .2. Surgical Palliative of Head and Neck-Cancer. Current Problems in Cancer. 1995 May;19(3):153-65.

Yeh KA, Goldberg M. Surgical Palliation of Cancer .1. Palliative Surgery for Thoracic Malignancies. Current Problems in Cancer. 1995 May;19(3):130-52.

Coia LR. The Use of Mitomycin in Esophageal Cancer. Oncology. 1993 Apr;50:53-62.

Coia LR, Soffen EM, Schultheiss TE, Martin EE, Hanks GE. Swallowing Function in Patients with Esophageal Cancer Treated with Concurrent Radiation and Chemotherapy. Cancer. 1993 Jan 15;71(2):281-6.

The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

esophageal cancer radiotherapy squamous-cell carcinoma chemotherapy therapy radiation-therapy stratification carcinoma trial Patterns of Care Study neoadjuvant chemoradiotherapy adenocarcinoma institution cancer radiation management LUNG-CANCER cisplatin trastuzumab corn esophagus human-breast-cancer GROWTH-FACTOR randomized controlled-trial esophageal carcinoma FACTOR-I RECEPTOR oral cavity control wild-type p53 percutaneous endoscopic gastrostomy IGFBP-3 EPITHELIAL-CELLS laparoscopic junction CANCER CELLS laparoscopy mitomycin-c carcinoid tumors Nodal ratio nutritional-status cardia long-term survival analysis induction positron emission tomography PLUS CISPLATIN chemoradiotherapy ADVANCED SOLID TUMORS pleural effusions endoscopic ultrasound fdg-pet ras mutations j-tube therapy-oncology-group intensity-modulated radiotherapy high-grade dysplasia oncology quality assurance primary liver-cancer colon cancer KERATINOCYTES primary management preoperative chemoradiation IGF phase-iii trial curative resection hair lung-cancer p53 gene gastrostomy massive hemoptysis bronchogenic-carcinoma ct quantitative evaluation trimodality Oncology DNA TOPOISOMERASE-I ductal adenocarcinoma FACTOR-BINDING PROTEIN-3 gene amplification cell-cycle pancreaticoduodenectomy cdkn2 gene gel- surgery human head toxicity ADJUVANT CHEMOTHERAPY radical radiation-therapy RANDOMIZED-TRIAL 2-STAGE DESIGNS adenovirus-mediated transfer complication g(1) phase ErbB2 mortality cell standard transformation cancer-cells cycle invitro mitomycin conformation polymorphism organ preservation intracavitary bleomycin exposure electrophoresis mutant p53 endoscopic jejunostomy nd-yag laser esophageal adenocarcinoma p53 p16 mycotoxins field cancerization survival TRANSGENIC MICE Lymph node Radiation therapy ADVANCED ESOPHAGOGASTRIC CANCER Her2 irinotecan GASTROESOPHAGEAL ADENOCARCINOMA prognostic-factors computed-tomography EXPRESSION Malnutrition neoadjuvant 3-dimensional conformal radiotherapy TGF-BETA haimen-city Ras gene-mutations Pancreatic cancer mammary epithelial-cells gastric cancer 5-fluorouracil infusion chemoradiation extrapleural pneumonectomy esophagectomy tumor suppressor Multiple cancers follow-up cervix republic-of-china extended lymphadenectomy ADVANCED GASTRIC-CANCER docetaxel